Q3 2024
|
14 |
1,034,026 |
GIL.TO, UTI, SONO, GMS
|
13F-HR
|
11/14/2024 |
000095012324011833 |
Q2 2024
|
14 |
1,121,961 |
GIL.TO, UTI, RCM, MODV
|
13F-HR
|
8/14/2024 |
000095012324008779 |
Q1 2024
|
11 |
1,084,877 |
GIL.TO, UTI, RCM, PRPL
|
13F-HR
|
5/15/2024 |
000095012324005628 |
Q4 2023
|
11 |
1,247,137 |
GIL.TO, GMS, UTI, MODV
|
13F-HR
|
2/14/2024 |
000095012324002588 |
Q3 2023
|
11 |
959,307 |
GIL.TO, GMS, MODV, SONO
|
13F-HR
|
11/14/2023 |
000095012323010949 |
Q2 2023
|
12 |
1,109,075 |
GIL.TO, GMS, PRPL, SONO
|
13F-HR
|
8/14/2023 |
000095012323008215 |
Q1 2023
|
12 |
1,319,483 |
GMS, GIL.TO, SONO, PRPL
|
13F-HR
|
5/15/2023 |
000095012323005445 |
Q4 2022
|
13 |
1,341,847 |
GMS, BLDR, PRPL, GIL.TO
|
13F-HR
|
2/14/2023 |
000095012323002659 |
Q3 2022
|
13 |
1,227,599 |
BLDR, GMS, PRPL, MODV
|
13F-HR
|
11/14/2022 |
000095012322012398 |
Q2 2022
|
14 |
1,131,802 |
BLDR, GMS, PRPL, MODV
|
13F-HR
|
8/15/2022 |
000095012322009518 |
Q1 2022
|
13 |
1,328,225 |
BLDR, GMS, PRPL, MODV
|
13F-HR
|
5/16/2022 |
000095012322006472 |
Q4 2021
|
11 |
1,307,617 |
BLDR, GMS, PRPL, MODV
|
13F-HR
|
2/14/2022 |
000095012322003037 |
Q3 2021
|
8 |
1,126,381 |
BLDR, MODV, GMS, PRPL
|
13F-HR
|
11/16/2021 |
000095012321015661 |
Q2 2021
|
8 |
1,127,579 |
BLDR, MODV, GMS, PRPL
|
13F-HR
|
8/16/2021 |
000095012321011553 |
Q1 2021
|
7 |
1,335,164 |
PRPL, BLDR, MODV, GMS
|
13F-HR
|
5/17/2021 |
000095012321007062 |
Q4 2020
|
10 |
1,218,655 |
PRPL, BMCH, MODV, GMS
|
13F-HR
|
2/16/2021 |
000095012321002860 |
Q3 2020
|
12 |
935,157 |
BMCH, PRPL, MODV, GIL.TO
|
13F-HR
|
11/16/2020 |
000095012320012175 |
Q2 2020
|
13 |
685,562 |
PRPL, BMCH, MODV, GIL.TO
|
13F-HR
|
8/14/2020 |
000095012320009104 |
Q1 2020
|
18 |
369,155 |
BMCH, MODV, PRPL, ID
|
13F-HR
|
5/15/2020 |
000095012320005334 |
Q4 2019
|
11 |
375,673 |
BMCH, PRPL, MODV, CNR
|
13F-HR
|
2/14/2020 |
000095012320002537 |
Q3 2019
|
15 |
362,405 |
BMCH, MODV, PRPL, BXC
|
RESTATEMENT
|
2/14/2020 |
000095012320002473 |
Q2 2019
|
13 |
309,415 |
MODV, BMCH, PRPL, LEGACY ACQUISITION CORP
|
13F-HR
|
8/14/2019 |
000095012319008393 |
Q1 2019
|
13 |
276,855 |
MODV, BMCH, LEGACY ACQUISITION CORP, RLH
|
13F-HR
|
5/15/2019 |
000095012319005475 |
Q4 2018
|
13 |
267,997 |
MODV, PRPL, BMCH, LEGACY ACQUISITION CORP
|
13F-HR
|
2/14/2019 |
000095012319002232 |
Q3 2018
|
9 |
246,095 |
MODV, RLH, PRPL, LEGACY ACQUISITION CORP
|
13F-HR
|
11/14/2018 |
000095012318011403 |
Q2 2018
|
9 |
259,462 |
MODV, PRPL, RLH, LEGACY ACQUISITION CORP
|
13F-HR
|
8/14/2018 |
000095012318008955 |
Q1 2018
|
10 |
248,589 |
MODV, PRPL, LEGACY ACQUISITION CORP, LHCG
|
13F-HR
|
5/15/2018 |
000095012318005804 |
Q4 2017
|
8 |
157,217 |
MODV, LEGACY ACQUISITION CORP, UTI, ADES
|
13F-HR
|
2/14/2018 |
000095012318002468 |
Q3 2017
|
5 |
134,613 |
MODV, UTI, ADES, BIOSCRIP INC
|
13F-HR
|
11/14/2017 |
000095012317010890 |
Q2 2017
|
8 |
163,771 |
MODV, BIOSCRIP INC, UTI, BLBD
|
13F-HR
|
8/14/2017 |
000095012317007921 |
Q1 2017
|
10 |
222,407 |
MODV, LHCG, ASNAQ, ADES
|
13F-HR
|
5/15/2017 |
000095012317005329 |
Q4 2016
|
7 |
221,631 |
MODV, BLBD, LHCG, ASNAQ
|
13F-HR
|
2/14/2017 |
000095012317002508 |
Q3 2016
|
10 |
285,094 |
MODV, BLBD, LHCG, ASNAQ
|
13F-HR
|
11/14/2016 |
000095012316022470 |
Q2 2016
|
9 |
239,686 |
MODV, LHCG, ASNAQ, BLBD
|
13F-HR
|
8/15/2016 |
000095012316020205 |
Q1 2016
|
11 |
257,846 |
MODV, ASNAQ, LHCG, BLBD
|
13F-HR
|
5/16/2016 |
000095012316017616 |
Q4 2015
|
11 |
246,294 |
MODV, LHCG, BLBD, ASNAQ
|
13F-HR
|
2/16/2016 |
000095012316015137 |
Q3 2015
|
8 |
248,020 |
MODV, LHCG, ASNAQ, BLBD
|
13F-HR
|
11/16/2015 |
000095012315012185 |
Q2 2015
|
8 |
295,007 |
MODV, LHCG, ASNAQ, BLBD
|
13F-HR
|
8/14/2015 |
000095012315009454 |
Q1 2015
|
8 |
331,879 |
MODV, LHCG, CROX, ACCURIDE CORP NEW
|
13F-HR
|
5/15/2015 |
000095012315006319 |
Q4 2014
|
9 |
310,820 |
MODV, LHCG, ADES, CROX
|
13F-HR
|
2/17/2015 |
000095012315003374 |
Q3 2014
|
8 |
280,093 |
MODV, LHCG, CROX, ADES
|
13F-HR
|
11/14/2014 |
000095012314012050 |
Q2 2014
|
10 |
297,795 |
MODV, LHCG, ACCURIDE CORP NEW, CROX
|
13F-HR
|
8/14/2014 |
000095012314009123 |
Q1 2014
|
12 |
258,766 |
MODV, LHCG, ACCURIDE CORP NEW, CROX
|
13F-HR
|
5/15/2014 |
000095012314006295 |
Q4 2013
|
11 |
235,522 |
LHCG, MODV, CROX, ACCURIDE CORP NEW
|
13F-HR
|
2/14/2014 |
000095012314002610 |